![Elizabeth Faust](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elizabeth Faust
Directeur/Bestuurslid bij
BIOMEA FUSION, INC.
Vermogen: - $ op 30-06-2026
Profiel
Elizabeth A. Faust is currently Independent Director at Biomea Fusion, Inc. since 2022 and Principal & Owner at Faust Consulting LLC since 2018.
Former roles include Executive Director-Regional Medical Liaisons at Amgen, Inc., Senior Director-Medical Affairs at Gloucester Pharmaceuticals, Inc. from 2008 to 2010, Vice President-Medical Affairs at Pharmacyclics LLC from 2013 to 2015, Executive Vice President-Medical Affairs at Tricida, Inc. from 2019 to 2020, Vice President-Clinical Research Sciences at Celgene Corp., Vice President-Medical Affairs at Kite Pharma, Inc. from 2016 to 2018, and Vice President-Medical Affairs at Pharmacyclics, Inc. from 2013 to 2015.
Education includes a doctorate from the University of California, Los Angeles, graduate studies at the University of California, Riverside, and undergraduate studies at Auburn University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BIOMEA FUSION INC -.--% | 10-06-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
Actieve functies van Elizabeth Faust
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOMEA FUSION, INC. | Directeur/Bestuurslid | 01-06-2022 |
Eerdere bekende functies van Elizabeth Faust
| Bedrijven | Functie | Einde |
|---|---|---|
| TRICIDA, INC. | Hoofd Techniek/Wetenschap/O&O | 01-08-2020 |
| CELGENE | Hoofd Techniek/Wetenschap/O&O | 01-11-2019 |
| KITE PHARMA INC | Hoofd Techniek/Wetenschap/O&O | 01-07-2018 |
| PHARMACYCLICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2015 |
Pharmacyclics, Inc.
 Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat cancer | Hoofd Techniek/Wetenschap/O&O | 01-11-2015 |
Opleiding van Elizabeth Faust
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
46
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Gloucester Pharmaceuticals, Inc.
 Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of cancer patients | Health Technology |
Tricida, Inc.
 Tricida, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparation products | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Auburn University
 Auburn University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Riverside
 University of California, Riverside Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Biomea Fusion, Inc.
 Biomea Fusion, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which engages in the discovery, development and commercialization of small molecules to treat patients with genetically defined cancers | Health Technology |
Pharmacyclics, Inc.
Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat cancer | Health Technology |
